Hutson P H, Dourish C T, Curzon G
Eur J Pharmacol. 1986 Oct 7;129(3):347-52. doi: 10.1016/0014-2999(86)90445-0.
Administration of 60 micrograms/kg s.c. of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT), a dose previously shown to cause hyperphagia in satiated rats (but not to cause the 5-HT behavioural syndrome) decreased 5-HIAA and 5-HIAA/5-HT ratio in several brain regions, the most marked effects being in pons + medulla oblongata, a region containing 5-HT cell bodies and ascending 5-HT axons. Micro-infusion of 8-OH-DPAT (250 and 500 ng) into the dorsal or medial raphe nuclei significantly increased food intake and feeding duration but did not produce the 5-HT behavioural syndrome. Results suggest that 8-OH-DPAT induced hyperphagia is mediated via a agonist action on somatodendritic 5-HT autoreceptors.
皮下注射60微克/千克的5-羟色胺1A受体激动剂8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT),先前的研究表明该剂量可使饱足大鼠产生食欲亢进(但不会引发5-羟色胺行为综合征),这降低了几个脑区中的5-羟吲哚乙酸(5-HIAA)及5-HIAA/5-羟色胺(5-HT)比值,最显著的影响出现在脑桥+延髓,该区域包含5-羟色胺细胞体和上行的5-羟色胺轴突。向中缝背核或中缝内侧核微量注射8-OH-DPAT(250和500纳克)可显著增加食物摄入量和进食持续时间,但不会产生5-羟色胺行为综合征。结果表明,8-OH-DPAT诱导的食欲亢进是通过对树突-体细胞5-羟色胺自身受体的激动剂作用介导的。